Racing Medication Reform Advocacy Website Launched

The Jockey Club and the Thoroughbred Owners and Breeders Association (TOBA) May 10 announced the launch of an advocacy is dedicated to the reform of horse racing medication rules.

Features of the new educational website include news, videos, scientific studies, and commentary in support of medication-free racing, as well as several action-oriented sections that enable industry participants to pledge their support for clean racing by contacting state racing commissions and signing petitions regarding medication reform.

The site will also maintain a substantial social media presence, including Facebook, Twitter, and YouTube.

"As the momentum continues to grow for a ban on the use of race-day medication in this country, we want to keep all industry stakeholders properly informed," said James L. Gagliano, president and chief operating officer of The Jockey Club, in a release. "This website provides a platform for advocates of medication reform to receive the latest updates and take action. It should also prove to be an invaluable information resource for regulators as they reconsider current medication rules in their respective jurisdictions."

"More than 75% of TOBA members support a measured phase-out of race-day medication," said Dan Metzger, TOBA president, in a statement. "Those members, as well as sales companies, prospective buyers and sellers, fans and international organizations, all want to see a true representation of quality that is based solely on a horse's natural athletic ability."

Additional information about can be obtained by contacting

About the Author

The Blood-Horse Staff

The Blood-Horse is the leading weekly publication devoted to international Thoroughbred racing and breeding. Since 1916, the staff of The Blood-Horse has served the Thoroughbred community with the highest standards of journalistic excellence to provide comprehensive and timely editorial coverage and analysis.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from Learn More